Case File №
#VI-2026-0442
Biolongevity Labs
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
43 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Ipamorelin | A Great | 4 | 7.3 | 6.3 | 8.0 | 16 May 2025 |
| GHK-Cu | A Great | 4 | 7.2 | 6.8 | 7.9 | 14 Jun 2025 |
| Retatrutide | C Okay | 11 | 6.5 | 4.4 | 8.0 | 31 Mar 2025 |
| PT-141 | C Okay | 3 | 5.7 | 4.2 | 7.0 | 13 Jun 2025 |
| BPC-157 | E Bad | 11 | 4.7 | 2.5 | 6.4 | 28 Mar 2025 |
| 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 25 Apr 2025 |
| AA Water | X N/A | 1 | 5.9 | 5.9 | 5.9 | 2 Apr 2025 |
| Abaloparatide | X N/A | 1 | 7.4 | 7.4 | 7.4 | 28 Mar 2025 |
| ACE-031 | X N/A | 2 | 6.8 | 6.3 | 7.2 | 21 May 2026 |
| Benzaldehyde CAS 100-52-7 | X N/A | 3 | 6.7 | 4.9 | 8.1 | 17 May 2026 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 16 Mar 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 3 | 6.0 | 5.0 | 7.5 | 21 May 2026 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 3 | 5.8 | 5.2 | 6.8 | 25 May 2026 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 9.2 | 9.2 | 9.2 | 3 Jul 2025 |
| Cardiogen | X N/A | 1 | 5.3 | 5.3 | 5.3 | 6 May 2025 |
| Chonluten | X N/A | 3 | 6.5 | 5.3 | 8.1 | 24 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 2 | 5.8 | 5.0 | 6.5 | 21 May 2026 |
| Clenbuterol | X N/A | 2 | 6.8 | 6.8 | 6.9 | 20 May 2026 |
| DHB (1-Test Cyp) Oral | X N/A | 3 | 6.7 | 5.7 | 7.4 | 24 May 2026 |
| Dihexa | X N/A | 1 | 6.7 | 6.7 | 6.7 | 13 Jun 2025 |
| Enclomiphene | X N/A | 1 | 6.7 | 6.7 | 6.7 | 25 Apr 2025 |
| GW-501516 (Cardarine) | X N/A | 2 | 4.8 | 2.2 | 7.4 | 24 May 2026 |
| IGF-1 LR3 | X N/A | 2 | 6.2 | 5.7 | 6.6 | 26 Jan 2026 |
| Ivermectin | X N/A | 3 | 6.0 | 4.3 | 7.2 | 24 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 2 | 7.2 | 6.7 | 7.6 | 24 May 2026 |
| Letrozole | X N/A | 2 | 5.9 | 5.6 | 6.3 | 23 May 2026 |
| Lipo-B 216mg | X N/A | 1 | 7.3 | 7.3 | 7.3 | 25 Apr 2025 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 3 | 7.4 | 5.2 | 9.4 | 25 May 2026 |
| MK-677 (Ibutamoren) Raw | X N/A | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 |
| MT-1 | X N/A | 2 | 6.6 | 5.6 | 7.6 | 19 Jan 2026 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 7.3 | 7.3 | 7.3 | 8 Jul 2025 |
| NandroMix 300 | X N/A | 3 | 6.4 | 4.8 | 7.7 | 20 May 2026 |
| P21 | X N/A | 2 | 7.8 | 7.6 | 8.0 | 21 May 2026 |
| Retatrutide Raw | X N/A | 2 | 5.7 | 4.1 | 7.2 | 20 May 2026 |
| S-23 Raw | X N/A | 2 | 7.5 | 7.4 | 7.5 | 19 Jan 2026 |
| SNAP-8 | X N/A | 2 | 6.7 | 6.1 | 7.2 | 25 May 2026 |
| Super Shred | X N/A | 1 | 4.0 | 3.8 | 3.8 | 25 Apr 2025 |
| Superdrol Oil | X N/A | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 |
| Sustanon 250 | X N/A | 1 | 5.1 | 5.1 | 5.1 | 27 Feb 2025 |
| Sustanon 400 | X N/A | 2 | 5.1 | 4.7 | 5.4 | 20 May 2026 |
| Tirzepatide Raw | X N/A | 3 | 5.9 | 4.9 | 6.8 | 17 May 2026 |
| Trenbolone Acetate | X N/A | 2 | 7.8 | 7.7 | 7.8 | 21 May 2026 |
| Winstrol Oil | X N/A | 1 | 5.7 | 5.7 | 5.7 | 24 Apr 2025 |
Exhibit II
Evidence Log
77 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Sustanon 250 | 5.0 B | 200mg/ml | 206.7mg/ml | +3.4% | 98.45% | 15sct1 | Lab D | Public |
| 24 May 2026 | Dihexa | 8.2 A | 100mg | 101.2mg | +1.2% | 97.38% | 0fk6n7 | Lab B | Public |
| 24 May 2026 | GW-501516 (Cardarine) | 4.9 C | 25mg | 30.4mg | +21.6% | 95.64% | x74v65 | Lab E | Public |
| 24 May 2026 | MT-1 | 6.9 A | 20mg | 24.4mg | +22.2% | 98.23% | h87p1z | Lab D | Public |
| 24 May 2026 | P21 | 8.0 A | 2mg | 2.0mg | -0.6% | 95.27% | qezltx | Lab B | Public |
| 24 May 2026 | Clenbuterol | 6.4 A | 25mg | 26.1mg | +4.4% | 95.65% | yqj5wg | Lab F | Public |
| 24 May 2026 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 8.5 A | 100mg/ml | 112.4mg/ml | +12.4% | 95.54% | x1r1qx | Lab F | Community |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 10.0 A | 5mg | 5.8mg | +16.4% | 98.66% | a31tar | Lab G | Public |
| 24 May 2026 | Superdrol Oil | 8.2 A | 200mg/ml | 184.7mg/ml | -7.7% | 96.56% | 9psive | Lab G | Community |
| 24 May 2026 | NandroMix 300 | 4.8 C | 200mg/ml | 217.8mg/ml | +8.9% | 96.03% | u7zxmq | Lab D | Community |
| 24 May 2026 | Chonluten | 7.0 A | 50mg | 44.3mg | -11.4% | 99.15% | gergq0 | Lab A | Public |
| 24 May 2026 | Enclomiphene | 4.0 C | 50mg | 48.6mg | -2.8% | 98.58% | yn1eke | Lab C | Community |
| 24 May 2026 | P21 | 9.6 A | 20mg | 21.3mg | +6.7% | 99.24% | bim736 | Lab C | Public |
| 24 May 2026 | S-23 Raw | 7.5 A | 1g | 1.2g | +16.5% | 99.32% | uzhtw3 | Lab B | Community |
| 23 May 2026 | Chonluten | 6.6 A | 10mg | 9.1mg | -9.1% | 97.06% | ppgwan | Lab G | Public |
| 23 May 2026 | MK-677 (Ibutamoren) Raw | 7.3 A | 500g | 502.2g | +0.4% | 97.94% | leoroj | Lab G | Public |
| 23 May 2026 | NandroMix 300 | 8.4 A | 100mg/ml | 122.3mg/ml | +22.3% | 98.97% | c86ygh | Lab E | Public |
| 23 May 2026 | Trenbolone Acetate | 6.8 A | 100mg/ml | 122.1mg/ml | +22.1% | 96.72% | d5vvo8 | Lab C | Public |
| 21 May 2026 | BPC157 10mg + TB500 10mg Blend | 5.6 B | 50mg | 46.3mg | -7.5% | 95.89% | bwzp3u | Lab B | Community |
| 21 May 2026 | Trenbolone Acetate | 6.9 A | 300mg/ml | 312.1mg/ml | +4.0% | 99.51% | wo92ss | Lab C | Community |
| 21 May 2026 | DHB (1-Test Cyp) Oral | 8.1 A | 100mg | 96.6mg | -3.4% | 99.85% | mswm8c | Lab D | Public |
| 19 May 2026 | 1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 | 6.1 A | 1g | 1.1g | +7.8% | 98.53% | 6sq24e | Lab B | Public |
| 19 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 4.0 C | 200mg/ml | 202.3mg/ml | +1.1% | 95.73% | r55cna | Lab C | Public |
| 19 May 2026 | Clenbuterol | 6.7 A | 10mg | 9.8mg | -1.8% | 95.59% | ddst70 | Lab C | Public |
| 17 May 2026 | Sustanon 400 | 5.3 B | 200mg/ml | 181.5mg/ml | -9.3% | 96.82% | yuhwpr | Lab E | Public |
| 29 Jan 2026 | AA Water | 7.1 A | 15mg | 15.9mg | +5.7% | 98.95% | u0r7d0 | Lab B | Public |
| 29 Jan 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.3 A | 100mg/ml | 115.6mg/ml | +15.6% | 95.85% | frjjd7 | Lab G | Community |
| 29 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 5.9 B | 10mg | 10.1mg | +0.9% | 98.41% | u8i9vk | Lab D | Community |
| 29 Jan 2026 | Tirzepatide Raw | 5.2 B | 5g | 4.4g | -12.9% | 96.22% | 07g549 | Lab F | Public |
| 26 Jan 2026 | Cardiogen | 7.2 A | 10mg | 9.6mg | -4.5% | 98.87% | 5s6x5a | Lab B | Public |
| 26 Jan 2026 | NandroMix 300 | 7.5 A | 250mg/ml | 258.6mg/ml | +3.4% | 96.71% | ubkljv | Lab G | Community |
| 26 Jan 2026 | SNAP-8 | 7.1 A | 50mg | 45.4mg | -9.3% | 99.96% | d1qymo | Lab B | Public |
| 19 Jan 2026 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 7.6 A | 300mg/ml | 282.3mg/ml | -5.9% | 98.02% | pkcrda | Lab E | Public |
| 19 Jan 2026 | Winstrol Oil | 4.3 C | 250mg/ml | 292.8mg/ml | +17.1% | 95.61% | i946pp | Lab A | Public |
| 9 Jan 2026 | Blend 300 (TRA/Mast P/Test P) | 6.1 A | 100mg/ml | 114.1mg/ml | +14.1% | 98.05% | siz03w | Lab G | Public |
| 9 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 6.4 A | 2mg | 2.3mg | +12.7% | 98.60% | ko03bv | Lab F | Public |
| 9 Jan 2026 | DHB (1-Test Cyp) Oral | 5.9 B | 20mg | 18.2mg | -8.8% | 98.98% | ksq3cn | Lab A | Public |
| 9 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.9 A | 30mg | 28.8mg | -4.1% | 97.04% | jcptob | Lab A | Public |
| 7 Jan 2026 | IGF-1 LR3 | 5.4 B | 5mg | 6.1mg | +21.2% | 97.88% | 7fkisu | Lab D | Public |
| 6 Jan 2026 | Letrozole | 7.3 A | 10mg | 9.1mg | -8.8% | 97.96% | 812opx | Lab G | Public |
| 29 Dec 2025 | Chonluten | 6.8 A | 5mg | 4.8mg | -4.9% | 96.15% | aga71a | Lab A | Community |
| 29 Dec 2025 | IGF-1 LR3 | 7.2 A | 30mg | 30.3mg | +1.1% | 99.19% | a6irdi | Lab F | Community |
| 29 Dec 2025 | Tirzepatide Raw | 4.4 C | 1g | 0.9g | -14.4% | 98.81% | g0kx50 | Lab F | Public |
| 12 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.5 A | 30mg | 32.1mg | +6.9% | 97.52% | fmtxah | Lab G | Public |
| 12 Dec 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.0 A | 50mg | 59.0mg | +18.1% | 96.91% | pwil14 | Lab B | Public |
| 6 Dec 2025 | GHK-Cu | 7.3 A | 50mg | 53.3mg | +6.6% | 99.83% | (no batch ID) | Lab E | Public |
| 5 Dec 2025 | SNAP-8 | 6.0 A | 2mg | 1.9mg | -4.9% | 95.04% | 89qyy4 | Lab B | Community |
| 23 Nov 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 8.0 A | 100mg/ml | 116.9mg/ml | +16.9% | 95.16% | 7gqau7 | Lab D | Community |
| 22 Nov 2025 | BPC-157 | 2.5 E | 10mg | 11.9mg | +19.0% | 98.40% | (no batch ID) | Lab G | Public |
| 17 Nov 2025 | Abaloparatide | 8.1 A | 30mg | 32.6mg | +8.8% | 97.67% | qdtfih | Lab G | Public |
| 17 Nov 2025 | ACE-031 | 7.1 A | 15mg | 18.4mg | +22.9% | 96.99% | 2b2r6i | Lab A | Public |
| 17 Nov 2025 | Benzaldehyde CAS 100-52-7 | 6.4 A | 5g | 5.7g | +14.6% | 95.32% | eu3up2 | Lab D | Public |
| 17 Nov 2025 | Benzaldehyde CAS 100-52-7 | 6.5 A | 10g | 9.6g | -4.3% | 98.57% | dj3o2q | Lab C | Public |
| 17 Nov 2025 | Retatrutide Raw | 4.0 C | 1g | 0.9g | -7.2% | 96.39% | tweeqq | Lab A | Community |
| 14 Nov 2025 | GW-501516 (Cardarine) | 4.0 C | 10mg | 11.2mg | +11.5% | 98.70% | w2yhmz | Lab D | Public |
| 14 Nov 2025 | Ivermectin | 6.9 A | 20mg | 24.2mg | +20.8% | 96.82% | udg7k7 | Lab E | Community |
| 14 Nov 2025 | Ivermectin | 5.1 B | 100mg | 88.1mg | -11.9% | 96.20% | 769sdn | Lab B | Public |
| 14 Nov 2025 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 7.1 A | 300mg/ml | 312.6mg/ml | +4.2% | 96.50% | laj4kq | Lab G | Public |
| 14 Nov 2025 | S-23 Raw | 9.8 A | 1g | 1.0g | +4.6% | 96.70% | k9hoak | Lab D | Public |
| 5 Nov 2025 | Benzaldehyde CAS 100-52-7 | 8.4 A | 100g | 112.4g | +12.4% | 95.98% | uw924z | Lab C | Public |
| 5 Nov 2025 | Tirzepatide Raw | 6.9 A | 500g | 611.5g | +22.3% | 99.18% | gj4215 | Lab D | Public |
| 4 Nov 2025 | Letrozole | 5.2 B | 100mg | 119.2mg | +19.2% | 98.28% | 9qe9yv | Lab F | Community |
| 4 Nov 2025 | MT-1 | 6.0 A | 10mg | 10.0mg | +0.2% | 96.46% | 5ffuo0 | Lab E | Public |
| 17 Oct 2025 | ACE-031 | 7.9 A | 15mg | 17.6mg | +17.1% | 95.46% | par42d | Lab E | Community |
| 17 Oct 2025 | Lipo-B 216mg | 8.4 A | 300mg/ml | 372.3mg/ml | +24.1% | 97.55% | f7wrbe | Lab C | Public |
| 17 Oct 2025 | Retatrutide Raw | 4.7 C | 5g | 4.7g | -6.0% | 96.25% | c2zeq8 | Lab F | Public |
| 17 Oct 2025 | Sustanon 400 | 4.0 C | 250mg/ml | 214.3mg/ml | -14.3% | 95.70% | szg5cc | Lab F | Public |
| 9 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.8 C | 15mg | 16.1mg | +7.2% | 99.32% | 05539l | Lab D | Public |
| 9 Oct 2025 | DHB (1-Test Cyp) Oral | 7.6 A | 100mg | 119.8mg | +19.8% | 99.51% | wqgrpo | Lab B | Public |
| 9 Oct 2025 | Ivermectin | 4.0 C | 10mg | 9.8mg | -2.5% | 95.53% | z5twao | Lab E | Public |
| 3 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.6 B | 20mg | 20.9mg | +4.3% | 97.21% | izp5cg | Lab C | Public |
| 3 Oct 2025 | Super Shred | 4.0 C | 250mg/ml | 253.5mg/ml | +1.4% | 95.36% | 4tpp08 | Lab G | Public |
| 12 Aug 2025 | PT-141 | 7.0 A | 5mg | 5.4mg | +8.0% | 100.00% | (no batch ID) | Lab G | VendorInvestigate |
| 25 Jul 2025 | BPC-157 | 4.2 D | 10mg | 12.2mg | +22.0% | 99.60% | (no batch ID) | Lab G | VendorInvestigate |
| 23 Jul 2025 | Retatrutide | 4.9 D | 10mg | 7mg | -30.0% | 100.00% | (no batch ID) | Lab G | VendorInvestigate |
| 10 Jul 2025 | GHK-Cu | 6.8 B | 50mg | 54.4mg | +8.8% | 99.95% | (no batch ID) | Lab E | VendorInvestigate |
| 10 Jul 2025 | GHK-Cu | 7.9 A | 50mg | 52.7mg | +5.4% | 99.95% | (no batch ID) | Lab E | VendorInvestigate |